- Heart failure is a growing health problem, estimated to affect approximately half a million Australians, each year.1
- The condition costs the Australian healthcare system $3.1 billion each year.2
- Less than half of Australians (37%) are aware of the link between heart failure and kidney disease.3
- Kidney disease affects approximately 2.7 million people nationwide.4
- One in two Australians (50%) are unaware that heart failure can be detected with a simple blood test called NT-proBNP.3
A new survey commissioned by
YouGov, on behalf of leading heart charity Hearts4heart, indicates more than 5
million Australians are not aware of the common comorbidities linked to heart
failure — such as kidney disease, type 2 diabetes, cancer, lung disease and
sleep-disordered breathing.3
Heart failure is estimated
to affect approximately half a million Australians, with more than 67,000 new
cases diagnosed each year.1 A serious, life-threatening condition,
heart failure is responsible for approximately 61,000 deaths annually, with
50-75% of deaths occurring within five years of diagnosis.2,5
Heart failure patients often navigate
multiple health conditions or comorbidities, such as an irregular heart rate or
rhythm, high blood pressure, kidney disease, type 2 diabetes, obesity, iron
deficiency, and mental health conditions like anxiety and depression.6,7,8
The survey revealed low
general awareness of the connection between heart failure and related
comorbidities, with a majority of Australians (63%) unaware of the specific
link between heart failure and kidney disease.3
Approximately
50% of individuals with heart failure are also living with chronic kidney
disease, one of the most common and dangerous comorbidities.9
According to the Australian Bureau of Statistics, 2.5 million people are
unaware they are living with signs of kidney disease.10 A Kidney
Health Check – which includes a blood test, urine test and a blood pressure
check – is the only way to detect kidney disease early, enabling timely
treatment to slow its progression.11
Chris Forbes, Chief
Executive Officer of Kidney Health Australia,
highlights the importance of early detection for all Australians, especially
those living with heart conditions.
“Heart failure and
cardiovascular disease are major risk factors for kidney disease, yet thousands
of Australians are unaware they may be living with both conditions. It is
really important that all people living with heart failure get a Kidney Health
Check to get in front of kidney disease.”
“Being diagnosed early is
key as early diagnosis allows for proactive treatment. New medications
available on the Pharmaceutical Benefits Scheme have shown they can halt the
progression of kidney disease by 15 years or more. Put simply, we can help turn
off the tap by raising awareness and encouraging patients to have proactive
discussions with their healthcare providers. This can make all the difference,”
he said.
Many Australians were also
found to be unaware of the link between increased heart failure risk and other
common comorbidities like type 2 diabetes (53%), cancer (62%), lung disease
(38%) and sleep-disordered breathing (63%).3
But the gaps in awareness go
beyond risk factors. Alarmingly, only one in two Australians (50%) know that
heart failure can often be detected through simple diagnostic
tools, including a routine stethoscope check or a straightforward blood
test.3
Professor Andrew Sindone,
Director of the Heart Failure Unit and Department of Cardiac Rehabilitation at
Concord Hospital and Head of Department of Cardiology at Ryde Hospital,
emphasises that early detection is essential to effectively manage heart
failure and triage patients onto the right intervention paths.11
One of the most effective diagnostic tools
GPs can access to confirm or rule out heart failure is the NT-proBNP blood
test. Professor Sindone was instrumental in having the NT-proBNP test added to
the Medicare Benefits Schedule (MBS) in November 2024, making it freely
accessible to eligible Australians.12
“The NT-proBNP test is
simple and effective. It helps identify if a patient with common heart failure
symptoms has high levels of a protein called BNP in the blood, which can
indicate heart failure. Often, symptoms of heart failure can be mistaken or masked
by those of other conditions, which makes the NT-proBNP test one of the most
clinically accurate and efficient ways to reach a diagnosis early.
“This test also alleviates
pressure on the patient and the healthcare system by reducing the need for
referrals to heart specialists or expensive tests like an echocardiogram in
order to diagnose heart failure. This is especially good news for those living
in remote and regional areas, where access to specialists can be limited,” said
Professor Sindone.
Tanya Hall, CEO and founder
of Hearts4heart, is dedicated to raising awareness about
heart failure, its associated comorbidities, and the importance of early
detection through initiatives like Heart Failure Awareness Week, taking place
this week (23 – 29 June 2025).
“It’s deeply concerning that
tens of thousands of Australians are unknowingly living with a life-threatening
condition. I lost my dad to heart failure when he was just 59 years old. No one
should ever have to experience that kind of loss. That’s why we want more
Australians to be aware of early detection tools like NT-proBNP so they are
empowered to have meaningful conversations with their healthcare professional.”
Ms Hall urges, “Anyone
experiencing common symptoms of heart failure, such as shortness of breath,
swelling in the legs, ankles or feet, struggling to sleep while laying down and
sudden weight gain - especially those over 65, should speak with their GP about
their risk and seek early screening as soon as possible.”
If you are concerned about
yourself, a friend or loved one who may be showing symptoms of heart failure,
visit www.hearts4heart.org.au to
access resources and information.